HEADER HYDROLASE 23-FEB-18 6FTQ TITLE CRYSTAL STRUCTURE OF HUMAN BETA-UREIDOPROPIONASE (BETA-ALANINE TITLE 2 SYNTHASE) - MUTANT T299C COMPND MOL_ID: 1; COMPND 2 MOLECULE: BETA-UREIDOPROPIONASE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BUP-1,BETA-ALANINE SYNTHASE,N-CARBAMOYL-BETA-ALANINE COMPND 5 AMIDOHYDROLASE; COMPND 6 EC: 3.5.1.6; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES; COMPND 9 OTHER_DETAILS: THE FIRST 6 AMINO ACIDS ARE A REMAINDER OF A CLEAVED COMPND 10 HIS-TAG C233 IS OXIDIZED TO CYSTEINE SULFINIC ACID T299 IS MUTATED TO COMPND 11 CYSTEINE SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: UPB1, BUP1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: AI; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET151/D-TOPO KEYWDS PYRIMIDINE DEGRADATION, N-CARBAMYL-BETA-ALANINE AMIDOHYDROLASE, 5- KEYWDS 2 FLUOROURACIL METABOLIZING ENZYME, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR D.DOBRITZSCH,D.MAURER REVDAT 2 17-JAN-24 6FTQ 1 REMARK REVDAT 1 21-NOV-18 6FTQ 0 JRNL AUTH D.MAURER,B.LOHKAMP,M.KRUMPEL,M.WIDERSTEN,D.DOBRITZSCH JRNL TITL CRYSTAL STRUCTURE AND PH-DEPENDENT ALLOSTERIC REGULATION OF JRNL TITL 2 HUMAN BETA-UREIDOPROPIONASE, AN ENZYME INVOLVED IN JRNL TITL 3 ANTICANCER DRUG METABOLISM. JRNL REF BIOCHEM. J. V. 475 2395 2018 JRNL REFN ESSN 1470-8728 JRNL PMID 29976570 JRNL DOI 10.1042/BCJ20180222 REMARK 2 REMARK 2 RESOLUTION. 2.08 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.08 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 26915 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.175 REMARK 3 FREE R VALUE : 0.199 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1453 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.08 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.13 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1957 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.95 REMARK 3 BIN R VALUE (WORKING SET) : 0.2190 REMARK 3 BIN FREE R VALUE SET COUNT : 113 REMARK 3 BIN FREE R VALUE : 0.2530 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2621 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 208 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 37.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.25 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.84000 REMARK 3 B22 (A**2) : 2.32000 REMARK 3 B33 (A**2) : -0.48000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.159 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.137 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.095 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.925 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2711 ; 0.009 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2474 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3682 ; 1.322 ; 1.940 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5725 ; 0.918 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 335 ; 6.273 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;34.189 ;23.233 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 441 ;11.340 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;16.153 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 399 ; 0.076 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3042 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 586 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1331 ; 0.619 ; 1.707 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1330 ; 0.619 ; 1.707 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1660 ; 1.112 ; 2.553 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1661 ; 1.111 ; 2.553 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1380 ; 0.522 ; 1.786 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1377 ; 0.522 ; 1.787 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2018 ; 0.906 ; 2.658 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3033 ; 4.956 ;20.947 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2992 ; 4.853 ;20.386 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 5 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 33 A 66 REMARK 3 ORIGIN FOR THE GROUP (A): 9.5870 -44.8228 -5.3623 REMARK 3 T TENSOR REMARK 3 T11: 0.2118 T22: 0.1754 REMARK 3 T33: 0.1389 T12: 0.0698 REMARK 3 T13: -0.0440 T23: 0.0053 REMARK 3 L TENSOR REMARK 3 L11: 5.8689 L22: 5.4762 REMARK 3 L33: 6.7811 L12: 1.7142 REMARK 3 L13: -2.7756 L23: -2.2247 REMARK 3 S TENSOR REMARK 3 S11: -0.1699 S12: -0.0628 S13: -0.5977 REMARK 3 S21: -0.1455 S22: -0.1001 S23: -0.5059 REMARK 3 S31: 0.4983 S32: 0.7323 S33: 0.2700 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 67 A 127 REMARK 3 ORIGIN FOR THE GROUP (A): -3.7884 -34.4195 0.2332 REMARK 3 T TENSOR REMARK 3 T11: 0.1119 T22: 0.1279 REMARK 3 T33: 0.0734 T12: -0.0011 REMARK 3 T13: 0.0107 T23: 0.0141 REMARK 3 L TENSOR REMARK 3 L11: 4.8823 L22: 2.0126 REMARK 3 L33: 2.4052 L12: -0.1855 REMARK 3 L13: -0.9572 L23: -0.1543 REMARK 3 S TENSOR REMARK 3 S11: -0.0452 S12: -0.1125 S13: -0.2562 REMARK 3 S21: 0.1750 S22: 0.1036 S23: 0.3325 REMARK 3 S31: 0.1105 S32: -0.2233 S33: -0.0585 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 128 A 201 REMARK 3 ORIGIN FOR THE GROUP (A): -8.3890 -21.7487 0.4372 REMARK 3 T TENSOR REMARK 3 T11: 0.1326 T22: 0.1852 REMARK 3 T33: 0.0565 T12: 0.0127 REMARK 3 T13: 0.0066 T23: -0.0386 REMARK 3 L TENSOR REMARK 3 L11: 4.1143 L22: 1.3175 REMARK 3 L33: 1.5966 L12: -0.0365 REMARK 3 L13: -0.6698 L23: 0.0253 REMARK 3 S TENSOR REMARK 3 S11: -0.0575 S12: -0.1985 S13: 0.3002 REMARK 3 S21: 0.0662 S22: 0.0845 S23: 0.1021 REMARK 3 S31: -0.2858 S32: -0.2525 S33: -0.0270 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 212 A 356 REMARK 3 ORIGIN FOR THE GROUP (A): -0.7454 -30.5144 -13.7879 REMARK 3 T TENSOR REMARK 3 T11: 0.0373 T22: 0.0887 REMARK 3 T33: 0.0068 T12: 0.0006 REMARK 3 T13: -0.0033 T23: -0.0095 REMARK 3 L TENSOR REMARK 3 L11: 1.2316 L22: 2.9676 REMARK 3 L33: 3.0501 L12: 0.0392 REMARK 3 L13: 0.4059 L23: -0.1841 REMARK 3 S TENSOR REMARK 3 S11: -0.0125 S12: 0.0156 S13: -0.0021 REMARK 3 S21: -0.0153 S22: -0.0026 S23: 0.1268 REMARK 3 S31: 0.0451 S32: -0.0528 S33: 0.0151 REMARK 3 REMARK 3 TLS GROUP : 5 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 357 A 384 REMARK 3 ORIGIN FOR THE GROUP (A): -0.8480 -11.7739 -33.9955 REMARK 3 T TENSOR REMARK 3 T11: 0.4137 T22: 0.1892 REMARK 3 T33: 0.2975 T12: -0.0581 REMARK 3 T13: -0.0539 T23: 0.0396 REMARK 3 L TENSOR REMARK 3 L11: 1.4842 L22: 3.3669 REMARK 3 L33: 6.0286 L12: 0.0649 REMARK 3 L13: -2.5886 L23: 2.0042 REMARK 3 S TENSOR REMARK 3 S11: 0.1678 S12: 0.2385 S13: 0.1641 REMARK 3 S21: -0.3700 S22: -0.1568 S23: 0.4122 REMARK 3 S31: -0.7864 S32: -0.4156 S33: -0.0110 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6FTQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 23-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1200008904. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-SEP-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.75 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9762 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XIA2 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28448 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.080 REMARK 200 RESOLUTION RANGE LOW (A) : 28.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 13.40 REMARK 200 R MERGE (I) : 0.12600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.08 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.13 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.1 REMARK 200 DATA REDUNDANCY IN SHELL : 13.00 REMARK 200 R MERGE FOR SHELL (I) : 0.81400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2VHH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.70 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.66 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% (W/V) PEG 3350 0.1 M HEPES PH 7.75 REMARK 280 300 MM NASCN 3 MG/ML ENZYME VARIANT, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 51.40400 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 51.40400 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 43.40750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 52.12200 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 43.40750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 52.12200 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 51.40400 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 43.40750 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 52.12200 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 51.40400 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 43.40750 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 52.12200 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6170 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 26080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -46.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 -51.40400 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 527 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -5 REMARK 465 ILE A -4 REMARK 465 ASP A -3 REMARK 465 PRO A -2 REMARK 465 PHE A -1 REMARK 465 THR A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 GLY A 3 REMARK 465 ALA A 4 REMARK 465 GLU A 5 REMARK 465 TRP A 6 REMARK 465 LYS A 7 REMARK 465 SER A 8 REMARK 465 LEU A 9 REMARK 465 GLU A 10 REMARK 465 GLU A 11 REMARK 465 CYS A 12 REMARK 465 LEU A 13 REMARK 465 GLU A 14 REMARK 465 LYS A 15 REMARK 465 HIS A 16 REMARK 465 LEU A 17 REMARK 465 PRO A 18 REMARK 465 LEU A 19 REMARK 465 PRO A 20 REMARK 465 ASP A 21 REMARK 465 LEU A 22 REMARK 465 GLN A 23 REMARK 465 GLU A 24 REMARK 465 VAL A 25 REMARK 465 LYS A 26 REMARK 465 ARG A 27 REMARK 465 VAL A 28 REMARK 465 LEU A 29 REMARK 465 TYR A 30 REMARK 465 GLY A 31 REMARK 465 LYS A 32 REMARK 465 VAL A 202 REMARK 465 GLY A 203 REMARK 465 ASP A 204 REMARK 465 PHE A 205 REMARK 465 ASN A 206 REMARK 465 GLU A 207 REMARK 465 SER A 208 REMARK 465 THR A 209 REMARK 465 TYR A 210 REMARK 465 TYR A 211 REMARK 465 GLY A 301 REMARK 465 ASP A 302 REMARK 465 GLY A 303 REMARK 465 LYS A 304 REMARK 465 LYS A 305 REMARK 465 ALA A 306 REMARK 465 HIS A 307 REMARK 465 GLN A 308 REMARK 465 ASP A 309 REMARK 465 PHE A 310 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 144 24.47 -151.37 REMARK 500 CSD A 233 -123.76 57.61 REMARK 500 SER A 324 -10.00 88.00 REMARK 500 SER A 331 154.00 -48.61 REMARK 500 VAL A 353 -63.24 -92.90 REMARK 500 THR A 380 83.17 -67.36 REMARK 500 REMARK 500 REMARK: NULL DBREF 6FTQ A 1 384 UNP Q9UBR1 BUP1_HUMAN 1 384 SEQADV 6FTQ GLY A -5 UNP Q9UBR1 EXPRESSION TAG SEQADV 6FTQ ILE A -4 UNP Q9UBR1 EXPRESSION TAG SEQADV 6FTQ ASP A -3 UNP Q9UBR1 EXPRESSION TAG SEQADV 6FTQ PRO A -2 UNP Q9UBR1 EXPRESSION TAG SEQADV 6FTQ PHE A -1 UNP Q9UBR1 EXPRESSION TAG SEQADV 6FTQ THR A 0 UNP Q9UBR1 EXPRESSION TAG SEQADV 6FTQ CYS A 299 UNP Q9UBR1 THR 299 ENGINEERED MUTATION SEQRES 1 A 390 GLY ILE ASP PRO PHE THR MET ALA GLY ALA GLU TRP LYS SEQRES 2 A 390 SER LEU GLU GLU CYS LEU GLU LYS HIS LEU PRO LEU PRO SEQRES 3 A 390 ASP LEU GLN GLU VAL LYS ARG VAL LEU TYR GLY LYS GLU SEQRES 4 A 390 LEU ARG LYS LEU ASP LEU PRO ARG GLU ALA PHE GLU ALA SEQRES 5 A 390 ALA SER ARG GLU ASP PHE GLU LEU GLN GLY TYR ALA PHE SEQRES 6 A 390 GLU ALA ALA GLU GLU GLN LEU ARG ARG PRO ARG ILE VAL SEQRES 7 A 390 HIS VAL GLY LEU VAL GLN ASN ARG ILE PRO LEU PRO ALA SEQRES 8 A 390 ASN ALA PRO VAL ALA GLU GLN VAL SER ALA LEU HIS ARG SEQRES 9 A 390 ARG ILE LYS ALA ILE VAL GLU VAL ALA ALA MET CYS GLY SEQRES 10 A 390 VAL ASN ILE ILE CYS PHE GLN GLU ALA TRP THR MET PRO SEQRES 11 A 390 PHE ALA PHE CYS THR ARG GLU LYS LEU PRO TRP THR GLU SEQRES 12 A 390 PHE ALA GLU SER ALA GLU ASP GLY PRO THR THR ARG PHE SEQRES 13 A 390 CYS GLN LYS LEU ALA LYS ASN HIS ASP MET VAL VAL VAL SEQRES 14 A 390 SER PRO ILE LEU GLU ARG ASP SER GLU HIS GLY ASP VAL SEQRES 15 A 390 LEU TRP ASN THR ALA VAL VAL ILE SER ASN SER GLY ALA SEQRES 16 A 390 VAL LEU GLY LYS THR ARG LYS ASN HIS ILE PRO ARG VAL SEQRES 17 A 390 GLY ASP PHE ASN GLU SER THR TYR TYR MET GLU GLY ASN SEQRES 18 A 390 LEU GLY HIS PRO VAL PHE GLN THR GLN PHE GLY ARG ILE SEQRES 19 A 390 ALA VAL ASN ILE CSD TYR GLY ARG HIS HIS PRO LEU ASN SEQRES 20 A 390 TRP LEU MET TYR SER ILE ASN GLY ALA GLU ILE ILE PHE SEQRES 21 A 390 ASN PRO SER ALA THR ILE GLY ALA LEU SER GLU SER LEU SEQRES 22 A 390 TRP PRO ILE GLU ALA ARG ASN ALA ALA ILE ALA ASN HIS SEQRES 23 A 390 CYS PHE THR CYS ALA ILE ASN ARG VAL GLY THR GLU HIS SEQRES 24 A 390 PHE PRO ASN GLU PHE CYS SER GLY ASP GLY LYS LYS ALA SEQRES 25 A 390 HIS GLN ASP PHE GLY TYR PHE TYR GLY SER SER TYR VAL SEQRES 26 A 390 ALA ALA PRO ASP SER SER ARG THR PRO GLY LEU SER ARG SEQRES 27 A 390 SER ARG ASP GLY LEU LEU VAL ALA LYS LEU ASP LEU ASN SEQRES 28 A 390 LEU CYS GLN GLN VAL ASN ASP VAL TRP ASN PHE LYS MET SEQRES 29 A 390 THR GLY ARG TYR GLU MET TYR ALA ARG GLU LEU ALA GLU SEQRES 30 A 390 ALA VAL LYS SER ASN TYR SER PRO THR ILE VAL LYS GLU MODRES 6FTQ CSD A 233 CYS MODIFIED RESIDUE HET CSD A 233 8 HETNAM CSD 3-SULFINOALANINE HETSYN CSD S-CYSTEINESULFINIC ACID; S-SULFINOCYSTEINE FORMUL 1 CSD C3 H7 N O4 S FORMUL 2 HOH *208(H2 O) HELIX 1 AA1 PRO A 40 GLU A 50 1 11 HELIX 2 AA2 PRO A 88 CYS A 110 1 23 HELIX 3 AA3 PRO A 134 ALA A 139 1 6 HELIX 4 AA4 GLY A 145 ASP A 159 1 15 HELIX 5 AA5 SER A 171 GLY A 174 5 4 HELIX 6 AA6 ILE A 232 HIS A 237 5 6 HELIX 7 AA7 HIS A 238 ASN A 248 1 11 HELIX 8 AA8 GLY A 261 HIS A 280 1 20 HELIX 9 AA9 PRO A 295 CYS A 299 5 5 HELIX 10 AB1 ASN A 345 ASN A 351 1 7 HELIX 11 AB2 ASN A 355 GLY A 360 1 6 HELIX 12 AB3 ARG A 361 LYS A 374 1 14 SHEET 1 AA1 8 ARG A 35 LYS A 36 0 SHEET 2 AA1 8 GLU A 53 PHE A 59 -1 O ALA A 58 N ARG A 35 SHEET 3 AA1 8 GLY A 336 ASP A 343 1 O LYS A 341 N PHE A 59 SHEET 4 AA1 8 ILE A 71 GLN A 78 -1 N VAL A 72 O LEU A 342 SHEET 5 AA1 8 ILE A 114 CYS A 116 1 O ILE A 114 N GLY A 75 SHEET 6 AA1 8 VAL A 161 ARG A 169 1 O VAL A 161 N ILE A 115 SHEET 7 AA1 8 LEU A 177 ILE A 184 -1 O ILE A 184 N VAL A 162 SHEET 8 AA1 8 VAL A 190 ARG A 195 -1 O THR A 194 N ALA A 181 SHEET 1 AA2 5 PHE A 221 THR A 223 0 SHEET 2 AA2 5 GLY A 226 VAL A 230 -1 O ILE A 228 N PHE A 221 SHEET 3 AA2 5 ILE A 252 SER A 257 1 O PHE A 254 N ALA A 229 SHEET 4 AA2 5 PHE A 282 ASN A 287 1 O CYS A 284 N ASN A 255 SHEET 5 AA2 5 TYR A 318 ALA A 320 -1 O TYR A 318 N ALA A 285 SHEET 1 AA3 2 VAL A 289 GLY A 290 0 SHEET 2 AA3 2 PHE A 313 TYR A 314 -1 O PHE A 313 N GLY A 290 SSBOND 1 CYS A 128 CYS A 299 1555 1555 2.04 LINK C ILE A 232 N CSD A 233 1555 1555 1.34 LINK C CSD A 233 N TYR A 234 1555 1555 1.34 CISPEP 1 LEU A 133 PRO A 134 0 5.91 CRYST1 86.815 104.244 102.808 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011519 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009593 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009727 0.00000